Pipeline

Overview

Overview


We are developing a pipeline of purpose-built, targeted medicines against genetic drivers of cancer. By designing highly selective medicines, we have the potential to deliver treatments that increase clinical benefit in genetically defined patient populations and fulfill the promise of precision medicine for appropriate patients.